Report for: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

Title	Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Published in	Cochrane database of systematic reviews, August 2011
DOI	10.1002/14651858.cd003460.pub3
Pubmed ID	21833945
Authors	Lisa Ruepert, A Otto Quartero, Niek J de Wit, Geert J van der Heijden, Gregory Rubin, Jean WM Muris
Abstract	Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. The role of pharmacotherapy for IBS is limited and focused mainly on symptom control.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	4	29%
Japan	2	14%
Romania	1	7%
Unknown	7	50%

Demographic breakdown

Type	Count	As %
Members of the public	10	71%
Practitioners (doctors, other healthcare professionals)	4	29%

Mendeley readers

The data shown below were compiled from readership statistics for 381 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United States	3	<1%
Australia	2	<1%
Germany	1	<1%
India	1	<1%
United Kingdom	1	<1%
Netherlands	1	<1%
Denmark	1	<1%
Peru	1	<1%
Greece	1	<1%
Other	1	<1%
Unknown	368	97%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	74	19%
Student > Master	49	13%
Researcher	40	10%
Student > Ph. D. Student	32	8%
Student > Postgraduate	30	8%
Other	85	22%
Unknown	71	19%

Readers by discipline	Count	As %
Medicine and Dentistry	165	43%
Nursing and Health Professions	27	7%
Psychology	21	6%
Agricultural and Biological Sciences	18	5%
Biochemistry, Genetics and Molecular Biology	17	4%
Other	45	12%
Unknown	88	23%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2022.

All research outputs

#1,250,165

of 23,098,660 outputs

Outputs from Cochrane database of systematic reviews

#2,872

of 12,367 outputs

Outputs of similar age

#5,512

of 121,607 outputs

Outputs of similar age from Cochrane database of systematic reviews

#18

of 106 outputs

Altmetric has tracked 23,098,660 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.3. This one has done well, scoring higher than 76% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,607 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.

We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.

Cochrane Database of Systematic Reviews

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context